-
EP0699439
European procedure
Extract from the Register of European Patents
EP About this file: EP0699439
| EP0699439 - Treatment of diseases caused by sebaceous gland disorders with acyl CoA cholesterol acyl transferase inhibitors [Right-click to bookmark this link] | Status | No opposition filed within time limit Status updated on 04.08.2000 Database last updated on 16.07.2024 | Most recent event Tooltip | 04.08.2000 | No opposition filed within time limit | published on 20.09.2000 [2000/38] | Applicant(s) | For all designated states Pfizer Inc. 235 East 42nd Street New York, NY 10017 / US | [N/P] |
| Former [1996/10] | For all designated states PFIZER INC. 235 East 42nd Street New York, N.Y. 10017 / US | Inventor(s) | 01 /
Mayne, James T. 43 Union Street Deep River, Connecticut 06417 / US | [1996/10] | Representative(s) | Moore, James William Pfizer Limited Ramsgate Road Sandwich Kent CT13 9NJ / GB | [N/P] |
| Former [1996/10] | Moore, James William, Dr. Pfizer Limited Ramsgate Road Sandwich Kent CT13 9NJ / GB | Application number, filing date | 95305594.4 | 10.08.1995 | [1996/10] | Priority number, date | US19940298735 | 31.08.1994 Original published format: US 298735 | [1996/10] | Filing language | EN | Procedural language | EN | Publication | Type: | A2 Application without search report | No.: | EP0699439 | Date: | 06.03.1996 | Language: | EN | [1996/10] | Type: | A3 Search report | No.: | EP0699439 | Date: | 26.06.1996 | [1996/26] | Type: | B1 Patent specification | No.: | EP0699439 | Date: | 06.10.1999 | Language: | EN | [1999/40] | Search report(s) | (Supplementary) European search report - dispatched on: | EP | 08.05.1996 | Classification | IPC: | A61K31/44, A61K31/17, A61K31/00, A61K9/06 | [1996/10] | CPC: |
A61K9/0014 (EP,US);
A61K31/00 (EP,US);
A61K31/17 (EP,US);
A61K31/44 (EP,US);
A61P17/00 (EP);
A61P17/10 (EP);
A61P43/00 (EP)
(-)
| Designated contracting states | AT, BE, CH, DE, DK, ES, FR, GB, GR, IE, IT, LI, LU, NL, PT, SE [1996/10] | Title | German: | Behandlung von durch Talgdrüse verursachten Erkrankungen mit Inhibitoren der Acyl CoA Cholesterin Acyltransferase | [1996/10] | English: | Treatment of diseases caused by sebaceous gland disorders with acyl CoA cholesterol acyl transferase inhibitors | [1996/10] | French: | Traitement des maladies provoquées par des troubles des glandes sébacés avec l'emploi d'inhibiteurs de l'acyl CoA cholestérol acyl transferase | [1996/10] | Examination procedure | 18.08.1995 | Examination requested [1996/10] | 05.01.1998 | Despatch of a communication from the examining division (Time limit: M04) | 20.03.1998 | Reply to a communication from the examining division | 24.11.1998 | Despatch of communication of intention to grant (Approval: Yes) | 29.03.1999 | Communication of intention to grant the patent | 22.06.1999 | Fee for grant paid | 22.06.1999 | Fee for publishing/printing paid | Opposition(s) | 07.07.2000 | No opposition filed within time limit [2000/38] | Fees paid | Renewal fee | 10.07.1997 | Renewal fee patent year 03 | 04.07.1998 | Renewal fee patent year 04 | 02.07.1999 | Renewal fee patent year 05 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [XD]WO9315058 (PFIZER [US]) [XD] 10-15 * page 7, line 7 - line 35 *; | [XD]WO9324458 (PFIZER [US], et al) [XD] 10-15 * page 13, paragraph 2 * * page 11, line 9 - line 10 * * page 12, line 19 *; | [XP] - "Toxicologic effects of a novel AcylCoA: cholesterol acyltransferase inhibitor in cynomongus monkeys", TOXICOL.PATHOL., vol. 22, no. 5, pages 510 - 8, XP002000703 [XP] 1-15 * page 515, column L, line 32 - line 35 * * page 514; figure 5 * * page 515, column L, line 1 - line 4 * DOI: http://dx.doi.org/10.1177/019262339402200505 | by applicant | US3729568 | US4703110 | EP0242610 | EP0245687 | US4716175 | EP0252524 | US4743605 | EP0293880 | EP0297610 | EP0335374 | EP0335375 | US4927928 | EP0386487 | EP0399422 | WO9015048 | US4994465 | EP0415123 | WO9104027 | EP0421456 | EP0439059 | - J.V. STRAUMFORD, "Vitamin A: Its Effects on Acne", NORTHWEST MED., (194308), vol. 42, pages 219 - 225 | - J.A.D. ANDERSON ET AL., "Vitamin A in Acne Vulgaris", BRITISH MEDICAL JOURNAL, (196308), vol. 2, pages 294 - 296 | - F.W. LYNCH ET AL., "Acne Vulgaris Treated with Vitamin A", ARCHIVES OF DERMATOLOGY, (194703), vol. 55, page 355, 357 | - G.H. MITCHELL ET AL., "Results of Treatment of Acne Vulgaris by Intramuscular Injections of Vitamin A", ARCHIVES OF DERMATOLOGY, (195110), vol. 64, pages 428 - 430 | - P. VON BEER, "Untersuchungen ueber die Wirkung Vitamin A-Saeure", DERMATOLOGICA, (196203), vol. 124, pages 192 - 195 | - G. STUTTGEN, "Zur Lokalbehandlung von Kerastosen mit Vitamin-A-Saeure", DERMATOLOGICA, (196202), vol. 124, pages 65 - 80 | - J.A. GOLDSTEIN ET AL., "Comparative effect of isotretinoin and etretinate on acne and sebaceous gland secretion", JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, (1982), vol. 6, doi:doi:10.1016/S0190-9622(82)70066-0, pages 760 - 765, XP023131635 DOI: http://dx.doi.org/10.1016/S0190-9622(82)70066-0 | - S.S. SHAPIRO ET AL., "Evaluation of Potential Therapeutic Entities for the Treatment of Acne", S.S. SHAPIRO ET AL., REICHERT, SHROOT, Tharmacology of Retinoids in the Skin, BASEL, KARGER, (1989), vol. 3, pages 104 - 122 | - R.W. LAMBERT, R.E. SMITH, "Effects of 13-cis-retinoic acid on the hamster Meibomian gland", JOURNAL OF INVESTIGATIVE DERMATOLOGY, (1989), vol. 93, no. 2, pages 321 - 325 | - N.J. LOWE, M. DAVID, "Systemic Retinoids in Psoriasis: Comparitive Efficacy and Toxicity", N.J. LOWE, M. DAVID, REICHERT, SHROOT, Pharmacology of Retinoids in the Skin, BASEL, KARGER, (1989), vol. 3, pages 104 - 122 | WO1992US06485 | WO1992US10886 | WO1993US03539 | US19930133206 | US19940251075 |